The effect of passive heating on heat shock protein 70 and interleukin-6: a possible treatment tool for metabolic diseases? by Steve Faulkner (1249419) et al.
The effect of passive heating on heat shock protein 70 and interleukin-6: a 
possible treatment tool for metabolic diseases? 
 
Faulkner, SH; Jackson, S; Fatania, G; and Leicht, CA 
 
National Centre for Sports and Exercise Medicine, School of Sport Exercise and 
Health Sciences, Loughborough University, Loughborough, Leicestershire, LE11 
3TU, United Kingdom 
 
Running Head: Passive heating - a treatment tool for metabolic diseases? 
 
Address for correspondence: 
Dr Steve H. Faulkner 
National Centre for Sports and Exercise Medicine,  
School of Sport Exercise and Health Sciences,  
Loughborough University,  
Loughborough, Leicestershire,  
LE11 3TU,  
United Kingdom 
 
Email: S.Faulkner2@lboro.ac.uk 
 
  
Abstract 
Increasing physical activity remains the most widely publicised way of improving 
health and wellbeing. However, in populations that benefit most from exercise, 
adherence is often poor and alternatives to exercise are important to bring about 
health improvements. Recent work suggests a role for passive heating (PH) and heat 
shock proteins (HSP) in improving cardio-metabolic health. The aim of this study was 
to investigate the expression of HSP70 and interleukin-6 in response to either exercise 
(EX) or PH and the subsequent effect on glucose control.  Fourteen males volunteered 
and were categorized lean (BMI 23.5 ± 2.2 Kg.m-2) or overweight (29.2 ± 2.7 Kg.m-2) 
and completed 60 minutes of either moderate cycling at a fixed rate of metabolic heat 
production (EX) or warm water immersion in 40˚C water (PH). Extracellular HSP70 
increased from baseline in both conditions with no differences between PH (0.98 ± 
1.1 ng.mL-1) or EX (0.84 ± 1.0 ng.mL-1, P=0.814). IL-6 increased following both 
conditions with a 2 fold increase after PH and 4 fold after EX. Energy expenditure 
increased by 61.0 ± 14.4 kcal.h-1 (79%) after PH. Peak glucose concentration after a 
meal immediately following PH was reduced when compared with EX (6.3 ± 1.4 
mmol.L-1 vs. 6.8 ± 1.2 mmol.L-1; P<0.05). There was no difference in 24-hour glucose 
area under the curve between conditions. These data indicate the potential for thermal 
therapy as an alternative treatment and management strategy for those at risk of 
developing metabolic disease where adherence, or ability to exercise may be 
compromised. 
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Abbreviations 
AMPK - 5' adenosine monophosphate-activated protein kinase  
AUC – Area under the curve 
BMI – Body mass index 
BP – blood pressure 
BSA – body surface area 
CGM – Continuous glucose monitor 
CI – confidence interval 
CV – coefficient of variation 
eHSP – extracellular heat shock protein 
ELISA - enzyme-linked immunosorbent sandwich assay  
ES – effect size 
EX – Exercise trial  
HDL-C - High density lipoprotein cholesterol 
?̇?𝐻𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝 - Metabolic heat production 
HSP – Heat shock protein 
iHSP – Intracellular heat shock protein 
IL-1ra – Interleukin 1 receptor antagonist 
IL-6 – Interleukin 6 
IL-10 – Interleukin 10 
JNK - c-Jun N-terminal kinase  
kDa – kilo Dalton 
LDL-C – Low density lipoprotein cholesterol 
LEAN – Lean participant group 
OW – Overweight participant group 
PH – Passive heating trial 
SD – Standard deviation 
SEM – Standard error of mean 
T2DM – Type 2 diabetes mellitus 
Tb  - body temperature 
Tc – core temperature 
Tm – muscle temperature 
Tsk – skin temperature 
TG – Triglyceride V̇CO2 –carbon dioxide production V̇O2 – oxygen uptake V̇O2max – Maximum volume of oxygen uptake 
∆T – change in temperature 
 
 
 
  
Introduction 
 Overweight and obesity are characterised by chronic inflammation and 
impairments to insulin sensitivity and glucose control. A multitude of factors 
contribute to enhancing health and wellbeing; increasing physical activity remains the 
most widely publicised way of doing so. However, in populations that benefit most 
from exercise, adherence is often poor, most likely due to medical conditions and 
disability,1 poor motivation and a lack of convenience.2,3 There are many factors 
involved in the development and treatment of insulin resistance, with the roles played 
by both thermal therapy and heat shock proteins (HSPs) receiving increased 
attention.4-7 Furthermore, it has been suggested that HSPs may provide an early 
indicator of the onset of metabolic diseases, such as type 2 diabetes (T2DM),8,9 whilst 
also acting as a possible biomarker for the chronicity of diabetes.10 
 HSPs are synthesised in response to a number of physiological stressors,11-13 
and are individually characterised by their molecular weight. The most widely studied 
HSP in humans is the 70 kDa family of HSPs which includes both the constitutive 
HSP73 and inducible HSP72 forms. HSPs have wide-ranging functions including 
their roles as thermo-protectants and involvement in protein synthesis.14 The resting 
level of extracellular HSP70 (eHSP70) appears to be related to adiposity and 
inflammation with elevations reported in obesity and T2DM, whereas resting 
intracellular HSP70 (iHSP70) is decreased in T2DM.9 A reduction in iHSP70 is an 
important component in the vicious cycle of chronic inflammation and reduced 
insulin signalling15,16 and the development of insulin resistance.17,18 Indeed, a 
reduction in iHSP70 has been reported in T2DM and correlates to insulin resistance 
and glucose disposal rates.19,20 
 Extracellular HSP70 is increased following acute exercise13 with the 
magnitude of change dependent on both the duration and intensity.21,22 A core 
temperature (Tc) threshold for elevations in eHSP70 has been suggested, with a 0.8-
1.5˚C increase in Tc being required in order to elevate eHSP70.23,24 Recently, thermal 
therapy has been demonstrated to stimulate HSP70 production, although to a lesser 
extent than following exercise,4,24 and may offer an alternative way by which the 
positive effects of HSP may be induced.9 
 The influence of thermal therapy on glycemic regulation and metabolic 
disease has primarily been investigated using rodent models.17,18,25-27. However, there 
are human data to suggest that local heating at the site of insulin infusion improves 
postprandial insulin action28,29  and may benefit long-term glycemic control29,30 and 
cardiovascular health in humans.31 However, the mechanisms by which such an effect 
may occur in humans remain to be elucidated.  Chung et al. were the first to 
demonstrate that passive heating of mice resulted in an elevation in iHSP70 which 
was protective against the deleterious effects of consuming a high fat diet.18 They 
report that in response to a high fat diet there was an increase in the phosphorylation 
of c-Jun N-terminal kinase (JNK). Such an increase has been linked to impaired 
insulin sensitivity due to JNK binding with the insulin receptor substrate, thus 
preventing the initiation of the insulin signalling cascade and resulting in a elevation 
in plasma glucose (For review the reader is directed to32). Importantly, Chung et al. 
demonstrated that passive heating attenuated hyperinsulinemia, glucose intolerance 
and insulin resistance and as a direct consequence of elevations in HSP70 and was 
closely associated with prevention of JNK phosphorylation. Therefore, there is a need 
to investigate how well data from these rodent models translate into human 
participants, with a specific focus on the ability of thermal therapy to elevate HSP70 
and improve glycemic control. 
HSPs may impact on the inflammatory state by directly inducing pro-
inflammatory cytokines. Regular exercise has been demonstrated to have a positive 
effect on the inflammatory profile that is suggested to occur as a consequence of the 
repeated exposure to an anti-inflammatory environment following each exercise 
bout.33 This may occur as a consequence of secretion of pro-inflammatory cytokines, 
including interleukin-6 (IL-6) that may in turn up-regulate anti-inflammatory 
cytokines.34 Importantly, it has been shown that HSP70 independently induces pro-
inflammatory cytokines.35,36 Therefore, thermal therapy may be able to replicate some 
of the anti-inflammatory benefits of exercise, which could help reduce the level of 
inflammation evident in many types of chronic disease. 
Whilst exercise has significant benefits to improving health, individuals with 
many types of chronic disease often experience low exercise tolerance and poor rates 
of adherence.1,37  Based on the above animal literature, there is evidence to suggest 
that thermal therapy may replicate some of the health benefits of  exercise and 
alleviate some of the comorbidities often associated with chronic diseases such as 
T2DM.38 If successful, the implementation of thermal therapy may help to lessen 
some of the financial burden of treating chronic by potentially reducing the 
dependence on pharmacological interventions. Thermal therapy could offer a simple 
home-based intervention that may appeal to individuals unable or unwilling to 
participate in regular exercise. 
The primary aim of this study was to investigate the expression of eHSP70 in 
response to either exercise (EX) or thermal therapy in the form of passive heating 
(PH) via warm water immersion. A secondary aim was to investigate the effect of 
body composition on the eHSP70 response. Finally, we wished to investigate the 
potential effect of passive heating on glycemic control in response to replicated 
dietary intake. It was hypothesised that both EX and PH would elevate eHSP70, with 
a larger magnitude of change following EX. It was further hypothesised that there 
would be a differential response in eHSP70 between lean and overweight participant 
groups.  
 
Methods 
Participants. A total of fourteen males volunteered to participate in the study 
and were split into two groups i) Lean (LEAN, n=7; BMI <25 kg.m-2, body fat <15% 
and fat mass < 12kg) and ii) Overweight (OW, n=7; BMI > 27.0 kg.m-2, body fat 
>20% and fat mass >25kg). Participant characteristics are provided in table 1. All 
participants were healthy non-smokers with no history of cardiovascular, 
haematological or metabolic disorders and had been weight stable for ≥ 3 months. 
Participants were habitually inactive; performing less than 1.5 hours of structured 
physical activity per week and had avoided any hot weather exposure in the previous 
two months, including frequent sauna or spa use.  
Ethical approval. Full ethical approval was granted by the Loughborough 
University Ethical Advisory Committee.  All procedures conformed to the principles 
defined in the Declaration of Helsinki. Participants were fully informed of the 
experimental protocols and any potential risks were identified before they provided 
their written consent to participate. 
Experimental overview. Participants visited the laboratory on three occasions. 
The preliminary visit to the laboratory consisted of initial measures including a blood 
profile, body composition and both submaximal and maximal oxygen uptake tests 
(V̇O2 max test). Visits two and three comprised the experimental trials which consisted 
of either 60 minutes of passive heating via warm water immersion (PH), or 60 
minutes of exercise at a fixed rate of metabolic heat production (EX) which were 
completed in a counterbalanced order and were matched for ∆Tc. On arrival, 
participants were asked to void their bladder and were weighed in minimal clothing 
and then fully instrumented. The first blood sample was then collected and muscle 
temperature measured. Participants then completed either PH or EX as detailed 
below. On completion of each trial a second blood sample and muscle temperature 
measure were obtained, with a final blood sample being taken 2 hours after 
completion (figure 1). Experimental trials were separated by a minimum of 5 days to 
reduce any acclimation effect39 and to minimise any effect of prior exercise or heating 
upon insulin sensitivity.40 All trials were completed at the same time of day to 
minimise effects of circadian variation. 
 Preliminary visit. Participants arrived in a fasted state and a capillary blood 
sample was drawn for assessment of total cholesterol, high-density lipoprotein 
cholesterol (HDL-C), low density lipoprotein cholesterol (LDL-C), glucose and 
triglycerides (TG) (Cardiochek, Polymer Technology Systems, Indianapolis, IN). 
Participants’ height and weight were recorded (Seca 360, Birmingham, UK), and BMI 
calculated. Body composition was determined with skinfold callipers (Harpenden, 
Warwickshire, UK) using the 7-site formula.41 Participants then completed a 
submaximal exercise test on an electronically braked cycle ergometer (Lode 
Excalibur Sport, Groningen, Netherlands) with an online gas analyser (Metamax 3B, 
Cortex Biophysik GmbH, Germany). The test comprised four stages, increasing by 20 
W every 4 minutes. V̇O2  and V̇CO2 were determined over a 30 second rolling average 
from the final minute of each stage. On completion of the submaximal test, 
participants were given a minimum of a 10-minute recovery period prior to 
commencing the V̇O2 max test. This test used a continual ramp protocol at a rate of 20 
W.min-1 until the participant reached volitional exhaustion. V̇O2 max was determined 
over a 30 second rolling average from the final minute of the test. 
Experimental trials. Seventy-two hours prior to the start of each experimental 
trial, participants reported to the laboratory where they were fitted with a continuous 
glucose monitor device (CGM; Freestyle Libre, Abbott Laboratories, Berkshire). The 
sensor was inserted on the posterior aspect of the upper arm, with interstitial glucose 
measured every 15 minutes. CGM data were analysed for 2-h post meal glucose area 
under the curve and peak glucose concentration.42 Participants were provided with 
scales (HoMedics Group Salter, Kent) and detailed instruction on how to measure 
dietary intake in order to accurately complete a 3-day diet diary during the first trial, 
which commenced 24 h before and ended 24 h after completion of trial 1. Participants 
were instructed to consume the first meal after each condition following a 
standardised 3-hour time period. Participants were required to replicate their dietary 
intake and timing of meals for the second trial.  
Exercise trial. Participants performed 1 hour cycling at a fixed rate of 
metabolic heat production (?̇?𝐻𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝) equivalent to 7 W/kg in an environmental chamber 
(25.6 ± 0.7°C; 49.8 ± 3.8% relative humidity, rh). The initial workload was 
determined from the submaximal test and external workload was manipulated 
throughout the 60 minutes in order to maintain ?̇?𝐻𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝  at 7 W/kg. Participants 
completed the exercise at a self-selected cadence. V̇O2 and V̇CO2  were recorded 
throughout using an online gas analyser. Airflow was provided by three fans stacked 
vertically, positioned 2.5m in front of the ergometer at an air speed of 1.5 m.s-1.  
Passive heating trial. Participants were seated in a water bath (40.2 ± 0.2 ˚C) 
and immersed up to the waist for 1 hour. Water was circulated throughout to ensure 
maintenance of water temperature. ?̇?𝑉O2 and  ?̇?𝑉CO2  were recorded throughout. 
Ambient conditions during the trial were 23.9 ± 0.9 ˚C; 49.9 ± 4.4 % rh.  
Owing to the effect of temperature and duration on HSP70 and IL-6 
expression, we attempted to match the change in core temperature between conditions 
by eliciting a 1˚C increase in core temperature. Furthermore, the duration of both 
exercise and passive heating was matched to limit the effect of intervention exposure 
time on key outcome measures. 
Instrumentation. Core temperature (TC) was measured using a rectal 
thermistor (Grant Instruments Ltd, Cambridge) inserted 10 cm beyond the anal 
sphincter. Wireless skin sensors (iButtons, DS1922, California, USA) were applied 
and secured by Medipore tape (3M, Berkshire, UK). Mean skin temperature (𝑇𝑇�𝑠𝑠𝑠𝑠) was 
calculated according to the formula of Ramanathan.43 Participants wore a heart rate 
monitor throughout (RS800, Kempele, Polar, Finland).  
Muscle temperature. Muscle temperature (Tm) was measured in the right 
vastus lateralis using a solid needle probe (MKA08050A275TS Ellab, Copenhagen, 
Denmark) immediately pre and post-trial. Following standard sterile procedure, the 
needle probe was first inserted to an initial depth of 3 cm beyond the muscle fascia 
where the temperature was allowed to stabilise before the probe was withdrawn to 
2cm and then 1cm depths, with the temperature recorded at each depth.   
Blood sampling. Venous blood samples were collected by venepuncture from 
an antecubital vein in the right arm into a 10 mL Vacutainer that had been pre-cooled 
and pre-treated with K3EDTA (BD Biosciences, San Diego, USA). Samples were 
obtained before and on completion of each heating protocol with a final sample taken 
120 minutes later (figure 1). Samples were stored on ice until they were centrifuged at 
3,500 rpm for 10 min at 4°C and the plasma stored at -80°C until subsequent analysis.  
Enzyme-linked immunosorbent assays. Plasma HSP70 (ENZ-101, AMP’D® hs 
HSP70, Enzo Life Sciences, Exeter, UK) and IL-6 (HS600B, Quantikine® HS IL-6, 
R&D Systems, Abingdon, UK) concentrations were analysed using enzyme-linked 
immunosorbent sandwich assays (ELISAs) according to the manufacturers’ 
instructions. Plasma HSP70 and IL-6 concentrations were determined in relation to a 
four-parameter standard curve (version 6.0 GraphPad Software, La Jolla, CA, USA). 
All samples were analysed in duplicate with a mean intra plate coefficient of variation 
(CV) of 4.5% for HSP70 and 5.8% for IL-6. The inter plate CV was 6.3% for HSP70 
and 6.1% for IL-6.   
Calculations. Energy expenditure during PH and EX was calculated via 
indirect calorimetery. Heat balance parameters were estimated via partitional 
calorimetery and are presented as the mean value for each condition. All parameters 
were calculated in W/m2 but presented as W/kg where appropriate. The rate of 
metabolic energy expenditure was estimated as: 
 
𝑀𝑀 (𝑊𝑊/𝑚𝑚2) =  ?̇?𝑉𝑂𝑂2  ∙ ��𝑅𝑅𝑅𝑅𝑅𝑅 − 0.70.3 � ∙ 𝑒𝑒𝑐𝑐� + ��1.0 − 𝑅𝑅𝑅𝑅𝑅𝑅0.3 � ∙ 𝑒𝑒𝑓𝑓�60 ∙ 𝐵𝐵𝐵𝐵𝐵𝐵 ∙ 1000  
(1) 
where RER is the respiratory exchange ratio and ec and ef represent the energy 
equivalent of carbohydrate (21.13 kJ) and fat (19.69 kJ) respectively per litre of O2 
consumed per minute (L.min-1). ?̇?𝐻𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝 was determined as the difference between M 
and the external work rate (W): 
 
?̇?𝐻𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝 (𝑊𝑊/𝑚𝑚2) = M – W    
(2)   
Mean body temperature (∆𝑇𝑇�𝑏𝑏) was estimated using the three-compartment model as 
follows: 
 
∆𝑇𝑇�𝑏𝑏  = (0.63 ∆ 𝑇𝑇𝑐𝑐) + (0.24 ∆𝑇𝑇�𝑠𝑠𝑠𝑠) + (0.13 ∆ 𝑇𝑇𝑚𝑚)  
(3) 
where ∆Tc represents the change in core temperature, ∆𝑇𝑇�𝑠𝑠𝑠𝑠 the change in mean skin 
temperature and ∆Tm the change in muscle temperature at a depth of 3cm.44 Area 
under the curve (AUC) was calculated using the trapezoid method. 
Statistical analysis. The normality and distribution of data was assessed using 
the Shapiro-Wilk normality test. Where data failed to meet the criteria of normal 
distribution the data were log transformed. Mean participant characteristics were 
compared using independent samples t-tests. Tc, 𝑇𝑇�𝑠𝑠𝑠𝑠, Tm, HSP70, IL-6, were analysed 
using repeated measures ANOVA. Where significance was obtained post hoc tests 
were completed using Sidak’s test for multiple comparisons. ?̇?𝐻𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝, ∆𝑇𝑇�𝑏𝑏 and energy 
expenditure were analysed using one-way ANOVA with Sidak’s test for multiple 
comparisons. Correlational analysis was done using Pearson’s correlation coefficient. 
Linear regression was used to analyse the relative contributions of ∆Tc , ∆Tsk, ∆Tm and 
∆𝑇𝑇�𝑏𝑏 to ∆HSP70 and ∆IL-6. The R2 value was employed to determine the variance 
explained by each predictor variable. Where reported, the adjusted R2 value is 
provided for multiple linear regression in order to account for the number of predictor 
variables in the model.  All statistical analyses were performed using GraphPad Prism 
(version 6.0 GraphPad Software, La Jolla, CA, USA). All data are presented as mean 
± SD unless otherwise stated. P values ≤ 0.05 were considered statistically significant. 
Effect sizes (ES) corrected for bias using Hedge’s g were calculated as the ratio of the 
mean difference to the pooled standard deviation of the difference, with 95% 
confidence intervals (95% CI) for differences also presented. The magnitude of the 
ES was classed as trivial (<0.2), small (0.2– 0.6), moderate (0.6– 1.2), large (1.2– 2.0) 
and very large (≥ 2.0).45 
 
Results 
 ?̇?𝐻𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝. There were differences in ?̇?𝐻𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝 between PH (1.9 ± 0.2 W/kg) and EX 
(7.3 ± 0.5 W/kg, P<0.001). ?̇?𝐻𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝 was successfully matched between groups for both 
PH  (LEAN 2.0 ± 0.2 W/kg, OW = 1.8 ± 0.2 W/kg, P=0.433, CI = -0.03 to 0.43, 
ES=0.9) and EX (LEAN 7.3 ± 0.4, OW 7.2 ± 0.5 W/kg; P=0.763, CI = -0.63 to 0.43, 
ES = 0.21). However, when lean body mass is accounted for, differences in ?̇?𝐻𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝 
were evident (LEAN 8.4 ± 0.4 W/kg/LBM-1; OW 9.8 ± 1.6 W/kg/LBM-1, P<0.05, CI 
= 0.04 to 2.76, ES=1.1). 
eHSP70. There was a main effect of time (P<0.005) but not condition (P = 
0.887) on the eHSP70 response (figure 2A). The increase in eHSP70 following PH 
and EX was 23% and 24% respectively (figure 2B). Across conditions ∆eHSP70 
correlated with mean Tm (r=0.485, P<0.05). ∆eHSP70 was negatively correlated to 
body mass (r = -0.400, P<0.05). Of the thermal variables, ∆Tm provided the best 
predictor of ∆HSP70, with the ∆Tm explaining 24.7% of the total variance in ∆HSP70 
(r=0.498, P<0.01). Body mass also predicted ∆HSP70, explaining 16.4% of the total 
variance (r = -0.405, P<0.05). When combined, ∆Tm and body mass provided the 
strongest predictor, accounting for 28% of the variance in ∆HSP70 (Adjusted R2 = 
0.280, r = 0.585, P<0.01). 
 IL-6. There was a main effect of time (P<0.001), condition (P<0.05) and an 
interaction effect (P<0.01, figure 2C) on IL-6 concentration. IL-6 was higher 
immediately following EX (1.74 ± 1.79 pg.mL-1) compared to PH (0.97 ± 0.86 pg.mL-
1, P<0.0001, ES=0.5) and equated to an increase of 346% after EX and 118% 
following PH (figure 2D) from baseline values. IL-6 had returned to baseline at 2h 
post for PH (0.58 ± 0.47 pg.mL-1) and EX (0.73 ± 0.79 pg.mL-1). When considering 
differences between LEAN and OW, there was a main effect of time (P<0.05) but not 
group (P = 0.533) on the IL-6 response. None of the thermal variables, nor body 
mass, provided an effective model for predicting the change in IL-6. 
Energy expenditure. There were no differences in resting metabolic rate 
between LEAN (1811.2 ± 82.3 kcal.day-1) and OW (1873.9 ± 140.7 kcal.day-1; P = 
0.330, ES = 0.5).  There was an overall effect of condition on energy expenditure 
during heating (P<0.0001) and an interaction effect (P<0.05). PH increased energy 
expenditure by 61.0 ± 14.4 kcal.h-1 compared to rest (P<0.0001, ES = 4.8), which 
equates to a 79.5% increase. EX resulted in an additional energy expenditure of 556.3 
± 92.0 kcal.h-1 compared to rest (P<0.0001, ES = 7.1), equating to a 721% increase. 
EX energy expenditure was greater for OW compared to LEAN (11.3 ± 1.9 kcal.min-1 
vs. 9.8 ± 0.9 kcal.min-1 respectively, P<0.05, ES = 1.0), resulting in an additional 
caloric expenditure from rest of 597.7 ± 107.9 kcal for OW (748%), and 515 ± 52.1 
kcal for LEAN (681%). During PH, there was no difference in the increase in energy 
expenditure between LEAN and OW (2.3 ± 0.3 kcal.min-1 vs. 2.3 ± 0.3 kcal.min-1   
respectively, P = 0.997, ES = 0.0). Caloric expenditure increased from rest by 63.4 ± 
16.6 kcal (84%) and 58.5 ± 12.7 kcal (74%) kcal for LEAN and OW respectively 
although there was no difference between groups (P=0.623, ES = 0.3). 
Substrate oxidation. Total EX carbohydrate oxidation was higher for OW 
(125.3 ± 20.8 g) compared to LEAN (92.5 ± 28.2 g; P<0.05, ES=1.3). There was a 
moderate effect of body mass on total carbohydrate oxidation in PH between OW (7.5 
± 4.2 g) and LEAN (13.2 ± 8.3 g, ES=0.83) although this did not reach significance 
(P=0.13). There was no difference between OW and LEAN in total fat oxidation 
during EX (P=0.46). There was a tendency for OW to display a greater total fat 
oxidation than LEAN in PH, although this did not reach statistical significance 
(10.6±1.54g vs. 9.0±3.1g; ES 0.7; P=0.13).   
 Continuous glucose monitoring. Owing to instances of poor compliance to diet 
replication and sensor malfunction and drop out, CGM analysis was only completed 
on 8 participants, with an unequal split between LEAN (n=3) and OW (n=5). 
Therefore, it was only possible to conduct analysis on PH compared to EX. Peak 
glucose concentration in response to the meal following PH (6.3 ± 1.4 mmol.L-1) was 
lower compared to the same meal after EX (6.8 ± 1.2 mmol.L-1; P<0.05, CI = -0.9 to 
1.9, ES = 0.4, figure 3a). There was no difference in glucose AUC for PH compared 
to EX following this meal (P=0.875, CI = -11.2 to 12.4, ES = 0.1 figure 3b). There 
were no differences in either peak glucose (meal 2 P=0.168, meal 3 P=0.266) or AUC 
(meal 2 P=0.070, meal 3 P=0.183) consumed in the subsequent 24h period. There 
were also no differences in total 24h AUC between PH and EX (P=0.168) 
Core temperature. There was a main effect of time (P<0.0001) and an 
interaction effect (P<0.0001), but no main effect of condition on ∆Tc (P = 0.112, 
figure 4a). PH ∆Tc was lower in OW compared to LEAN from 35 minutes (P<0.05), 
although by 60 minutes there was no difference in ∆Tc  (1.0 ± 0.2˚C vs. 0.9 ± 0.2˚C, 
LEAN vs. OW respectively P = 0.089, CI = -0.13 to 0.33, ES = 0.5). There were no 
differences in ∆Tc between OW and LEAN during EX at any time point, with ∆Tc at 
60 minutes being 0.8 ± 0.1˚C vs. 0.8 ± 0.2˚C for LEAN and OW respectively 
(P=0.999). 
 Skin temperature. There were main effects of time (P<0.0001), condition 
(P<0.0001) and an interaction effect (P<0.0001) on ∆𝑇𝑇�𝑠𝑠𝑠𝑠 (figure 4B). There were no 
differences in ∆𝑇𝑇�𝑠𝑠𝑠𝑠 between OW and LEAN following EX (LEAN 1.7 ± 0.7˚C vs OW 
1.7 ± 1.6˚C, P=0.999, ES=0.0) or PH (LEAN 4.2 ± 0.4˚C vs OW 4.7 ± 0.6˚C, 
P=0.095, ES=0.9). 
 Muscle temperature. There was an effect of depth on ∆Tm  (P<0.001), but no 
effect of condition (P=0.285) or interaction (P=0.111, figure 4C). Following PH, the 
∆Tm was greater for LEAN compared to OW at a depth of 1cm (LEAN, 2.5 ± 0.8˚C; 
OW 1.9 ± 0.6˚C, P<0.0005, CI = -0.2 to 1.4, ES=0.8) and 3cm (LEAN, 2.3±0.6˚C; 
OW 1.9± 0.7, P<0.005, CI = -0.4 to 1.2, ES=0.6). After EX, ∆Tm was only different at 
1cm (LEAN, 2.3±0.6˚C; OW 2.0 ± 0.7, P<0.005, CI = -0.5 to 1.1, ES = 0.4). 
 Mean body temperature. There was a difference in ∆𝑇𝑇�𝑏𝑏  between conditions 
(P<0.0001, figure 4D). There were differences between LEAN PH and LEAN EX 
(1.7 ± 0.3˚C vs. 1.1 ± 0.3 ˚C, P<0.005, CI = 0.3 to 1.0, ES = 1.9); OW PH and OW 
EX (1.8 ± 0.2˚C vs. 1.0 ± 0.4˚C; P<0.001, CI = 0.4 to 1.2, ES = 2.4). There were no 
differences between LEAN and OW within the same condition (both P>0.9). 
 Heart rate. There were significant effects of time, condition and interaction 
effect of heart rate (all P<0.0001). Mean percentage HRmax EX was 78±8% compared 
to 54±7% in PH (P<0.0001). There were no differences in the mean percentage of 
HRmax between groups for either PH (LEAN = 54.0 ± 6.0% vs. OW = 55.2 ± 6.2%, 
P=0.719) or EX (LEAN = 78.5 ± 7.3%; OW = 81.7 ± 7.4%, P=0.428).  
 
Discussion 
 The primary outcome of the present study was that the concentration of 
eHSP70 in the plasma was similar between EX and PH when both conditions were 
matched for ∆Tc, with ∆Tm being the best individual predictor of ∆eHSP70, 
explaining ~25% of the total variance. This suggests that changes to Tm may in part 
determine the appearance of eHSP70. An important secondary outcome is the 
increase in energy expenditure evident as a consequence of PH. This has important 
implications for the use of PH as a future intervention that may help to moderate body 
mass, particularly for individuals unable or unwilling to complete regular physical 
activity. However, we recognise that PH should be coupled with dietary manipulation 
to maximise any potential benefit to body composition.  Finally, the reduction in peak 
glucose in the meal following PH compared to EX suggests that PH may have a 
beneficial effect on glycaemic regulation and provide an alternative or augmentative 
intervention by which individuals with metabolic diseases may be able to improve 
their glycemic control. However, additional research needs to be conducted to 
confirm these data in larger cohorts over a prolonged period of time. 
The HSP70 response may be hindered by excess body mass. Regression 
analysis demonstrated a link between body mass and the ∆eHSP70. A greater body 
mass was associated with an impaired eHSP70 response to heating, via either EX or 
PH, explaining 16% of the total variance. Such variation may be indicative of an 
impaired HSP response in overweight individuals in the face of physiological stress 
and would likely be compounded by low aerobic capacity.46 The implications for such 
a deficiency are wide ranging and may increase susceptibility to metabolic 
disease,46,47 impaired vascular function,48 and even contribute to the impaired 
thermoregulatory control evident in individuals with diabetes.49  
 Whilst there were no clear differences in the HSP70 response between either 
PH or EX, there were clear differences in the IL-6 response. Previous work has shown 
that temperature increases independently elevate IL-6.50 However, the present data do 
not support the view that skeletal muscle may act as a “heat stress sensor” triggering a 
subsequent cytokine response, as none of the thermal measures taken during the trials 
were effective predictors of ∆IL-6 and could not account for a significant proportion 
of the variation in IL-6 following heating. Our data also indicate that the difference in 
IL-6 between PH and EX is not due to HSP70 induction of IL-6,35,36 as ∆HSP70 was 
similar following PH and EX. This suggests the IL-6 response to exercise occurs 
independently of HSP70 expression and is more dependent on intensity and duration 
of exercise,51 than exposure to heat stress. IL-6 combined with its receptor (IL-6R), 
may also have a positive effect on insulin independent glucose uptake at rest.52 
Should chronic PH enhance IL-6R expression as is evident following exercise 
training,53 interventions capable of increasing both IL-6 and IL-6R, may provide a 
therapeutic basis for improving glycemic control. Moreover, it has recently been 
shown that acute passive heating elevates the anti-inflammatory cytokines IL-1ra and 
IL-10,54 suggesting that chronic passive heating may benefit the inflammatory profile 
in a similar way to exercise. However, long-term investigation of PH is required to 
corroborate this hypothesis.  
 Although the sample size for analysis of the glycemic response to PH and EX 
was somewhat limited, the fact that comparable glycemic profiles were evident 
between PH and EX is interesting. Given the acute effect of exercise on improving 
glucose control as a consequence of improved insulin sensitivity, 55 this is a 
somewhat surprising result. However, it has recently been shown that heat stress 
activates insulin independent glucose transport via 5' adenosine monophosphate-activated protein kinase (AMPK) activation.56 In response to the heat stress 
stimulus, a reduction in muscle adenosine triphosphate, phosphocreatine and glycogen 
was reported, indicating a significant energy cost to the heating protocol and hence 
activation of AMPK. This suggests that, acutely at least, heat stress may improve 
glucose uptake due to increased energy expenditure. Further work needs to be 
conducted to establish the exact mechanisms by which PH may exert such an effect.   
 In addition to benefits to metabolic regulation, PH has been shown to benefit 
cardiovascular health. In a recent meta-analysis Laukkanen et al., report that lifelong 
sauna use reduced cardiovascular and all cause mortality, with the largest benefits 
associated with more frequent sauna use.57 Although this relationship does not 
establish causality31,58 it is nonetheless an interesting link that is supported by recent 
investigations.59-61 PH appears to improve vascular function, with improvements to 
flow-mediated dilatation, arterial stiffness and blood pressure reported after 8 weeks 
of PH.59 Moreover, Thomas et al., have shown that 30 minutes of PH can induce a 
significant shear stress response and a reduction in mean arterial pressure in patients 
with peripheral arterial disease.62 Furthermore, in a healthy cohort who underwent 
matched duration PH or exercise, the PH group demonstrated a greater shear stress 
response compared to that in response to exercise.60 Based on heart rate responses, the 
cardiovascular strain in the present study was comparable to that of Thomas et al., 
which elicited ~50% HRmax during their immersion protocol.60 These recent findings 
indicate that PH has the potential to induce significant systemic benefits, which in 
some instances may be comparable to or even greater than the effects evident 
following exercise. 
 There are a few limitations with the present investigation. Firstly the omission 
of a measure of iHSP70, either derived from skeletal muscle or leukocytes makes it 
difficult to draw firm conclusions on the potential intracellular effect of PH and 
glycemic regulation. Without direct measures of iHSP70, in addition to JNK and 
other molecules in the insulin-signalling cascade, it is difficult to derive the exact 
effect of PH on acute glycemic control. Therefore, we are limited to discussing the 
relationship between eHSP70 and iHSP70 and that an increase in the extracellular 
component is reflective of changes in the intracellular compartment. Future 
investigation should employ techniques to measure both iHSP70 and eHSP70 to 
enable greater understanding of the effect of PH on the intracellular to extracellular 
ratio. Secondly, the relatively small sample size of this study, which may limit the 
statistical power of our experiments. We acknowledge that further experiments with 
larger cohorts should be conducted in order to replicate the present data. 
 In summary, the data presented here demonstrate that both acute PH and EX 
result in comparable increases in HSP70. It is suggested that ∆HSP70 is sensitive to 
the ∆Tm. The elevations in both HSP70 and IL-6 may promote an anti-inflammatory 
milieu and help combat the chronic inflammation associated with many disease states. 
The increase in energy expenditure following PH demonstrates a systemic effect of 
PH, which has the ability to reduce adipose tissue and further contribute to reducing 
inflammation. However, it should be noted that exercise still offers the greatest 
overall benefit to weight control and metabolic health. Finally, in agreement with that 
of other authors, the present data indicate that PH might provide an alternative to 
exercise in some individuals who are too physically impaired to undertake prolonged 
aerobic activity to improve their cardio-metabolic health. The possible therapeutic 
benefits of PH require more extensive investigation. 
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 Figure 1: Schematic representation of the experimental trials. The first meal after each 
intervention was consumed after 3-hours. Dietary intake was replicated between 
conditions. PH, passive heating; EX, exercise; CGM, continuous glucose monitoring  
 
Figure 2: The effect of 60 minutes passive heating at 40˚C, exercise at 7 W/kg and 
body composition on IL-6 and HSP70. A) The effect of passive heat and exercise on 
HSP70; B) the change in IL-6 in response to heating;  C) the effect of passive heat 
and exercise on IL-6; D) the change in IL-6 in response to heating. *above the line 
denotes main effect of time. †denotes difference between passive heating and 
exercise. Data presented as mean ± SEM 
 
 
Figure 3: A) Passive heating resulted in a reduction in peak interstitial glucose 
concentration compared to exercise in the meal immediately following the 
intervention. B) There was no effect of either intervention on the total glucose area 
under the curve (AUC) in the meal following either passive heating or exercise. 
*denotes passive different to exercise (P<0.05). Data presented as mean ± SEM. n=8 
   
 
 
Figure 4: The effect of 60 minutes passive heating at 40˚C, exercise at 7 W/kg and 
body composition on determinants of mean body temperature. A) the change in core 
temperature, B) change in mean skin temperature, C) muscle temperature at depths of 
1cm, 2cm and 3cm, D) change in mean body temperature. *above line denotes main 
effect of time,  * denotes difference between lean (LEAN) and overweight 
(OW)groups in the passive heating condition (P<0.05). †denotes difference between 
LEAN and OW groups in the exercise condition (P<0.05) **denotes difference 
between passive heating (PH) and exercise (EX) within each group. Data presented as 
mean ± SEM 
  
Table 1. Participant characteristics.  
 
Lean Overweight 
Age (years) 23.9 ± 3.5 30.7 ± 12.0 
Height (m) 1.83 ± 0.05 1.78 ± 0.05* 
Weight (kg) 78.9 ± 7.01 92.3 ± 12.3* 
BMI (kg.m2) 23.5 ± 2.2 29.2 ± 2.7** 
Waist (cm) 79.6 ± 4.8 92.9 ± 8.2** 
Hip (cm) 99.6 ± 4.4 105.1 ± 6.8 
Waist:Hip 0.80 ± 0.03 0.88 ± 0.04** 
BP Systolic 130 ± 14 137 ± 10 
BP Diastolic 77 ± 12 87 ± 0 
Cholesterol (mmol.L-1) 3.27 ± 0.54 3.71 ± 1.04 
LDL-C (mmol.L-1) 1.5 ± 0.5 1.8 ± 0.6 
HDL-C (mmol.L-1) 1.3 ± 0.3 1.2 ± 0.2 
Glucose (mmol.L-1) 4.6 ± 0.6 4.1 ± 0.8 
Triglyceride (mmol.L-1) 1.1 ± 0.2 1.6 ± 0.8 
Body fat (%) 12.5 ± 5.5 20.3 ± 1.6*** 
Fat Mass (kg) 10.1 ± 5.1 28.1 ± 9.9** 
Lean mass (kg) 68.8 ± 4.2 64.2 ± 6.9 V̇O2 max (L.min-1) 3.86 ± 0.35 3.35 ± 0.81 V̇O2 max (mL.kg.min-1) 49.03 ± 5.74 36.60 ± 9.66* 
Percent V̇O2 max  – EX (%) 53.9 ± 7.5 69.2 ± 10.2** 
Percent V̇O2 max  – PH (%) 18.3 ± 6.7 25.5 ± 6.7 
Basal Metabolic Rate (kcal.day-1) 1811.2 ± 82.3 1873.9 ± 140.7 
Data presented as mean ± SD. Asterix denotes * (P<0.05); ** (P < 0.01); *** (P<0.005). Abbreviations: BMI – Body mass 
index, BP – blood pressure, EX – Exercise trial, HDL – High density lipoprotein, LDL – Low density lipoprotein, PH – Passive 
heating trial, TG – Triglyceride 
 
 
 
 
 
  
 
